Indication
Prevention of xerostomia secondary to radiation therapy
Prevention of xerostomia secondary to radiation therapy refers to prophylactic clinical strategies aimed at averting or mitigating salivary gland hypofunction and the subjective sensation of dry mouth in patients receiving ionizing radiation, most notably for head and neck malignancies. Read more about Prevention of xerostomia secondary to radiation therapy
5 drugs 5 manufacturers
Drugs that treat it
Common Prevention of xerostomia secondary to radiation therapy therapies.
AMIFOSTINE (amifostine crystalline)
ETHYOL (amifostine crystalline)
ETHYOL (amifostine crystalline)
ETHYOL (amifostine crystalline)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of xerostomia secondary to radiation therapy refers to prophylactic clinical strategies aimed at averting or mitigating salivary gland hypofunction and the subjective sensation of dry mouth in patients receiving ionizing radiation, most notably for head and neck malignancies.
Ionizing radiation directly damages the secretory acinar cells, microvasculature, and stem cell compartments within major and minor salivary glands, leading to progressive inflammation, oxidative stress, and glandular fibrosis.
Clinically, this impairment results in markedly diminished saliva volume and altered salivary composition, predisposing affected individuals to debilitating complications such as oral mucositis, rampant dental caries, dysphagia, dysgeusia, and opportunistic oral infections.
Preventative interventions focus on preserving glandular architecture and baseline secretory capability before irreversible radio-induced destruction occurs.
- nih.gov
Prevention of xerostomia secondary to radiation therapy refers to prophylactic clinical strategies aimed at averting or mitigating salivary gland hypofunction and the subjective sensation of dry mouth in patients receiving ionizing radiation, most notably for head and neck malignancies Ionizing radiation directly damages the secretory acinar cells, microvasculature, and stem cell compartments within major and minor salivary glands, leading to progressive inflammation, oxidative stress, and gland...
- nih.gov
Prevention of xerostomia secondary to radiation therapy refers to prophylactic clinical strategies aimed at averting or mitigating salivary gland hypofunction and the subjective sensation of dry mouth in patients receiving ionizing radiation, most notably for head and neck malignancies
- nih.gov
Ionizing radiation directly damages the secretory acinar cells, microvasculature, and stem cell compartments within major and minor salivary glands, leading to progressive inflammation, oxidative stress, and glandular fibrosis
- aquoralspray.com
Clinically, this impairment results in markedly diminished saliva volume and altered salivary composition, predisposing affected individuals to debilitating complications such as oral mucositis, rampant dental caries, dysphagia, dysgeusia, and opportunistic oral infections
- cancernetwork.com
Preventative interventions focus on preserving glandular architecture and baseline secretory capability before irreversible radio-induced destruction occurs
Personalize your experience
Follow Prevention of xerostomia secondary to radiation therapy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.